292 related articles for article (PubMed ID: 34920123)
1. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA Taurine-Upregulated Gene1 (TUG1) Promotes Tumor Growth and Metastasis Through TUG1/Mir-129-5p/Astrocyte-Elevated Gene-1 (AEG-1) Axis in Malignant Melanoma.
Long J; Menggen Q; Wuren Q; Shi Q; Pi X
Med Sci Monit; 2018 Mar; 24():1547-1559. PubMed ID: 29543785
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Long Noncoding RNA TUG1 Promotes Bladder Cancer Cell Proliferation, Migration, and Invasion by Inhibiting miR-29c.
Guo P; Zhang G; Meng J; He Q; Li Z; Guan Y
Oncol Res; 2018 Aug; 26(7):1083-1091. PubMed ID: 29321088
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Lu P; Jiang Y; Xia Z
Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
[TBL] [Abstract][Full Text] [Related]
5. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
Xie C; Chen B; Wu B; Guo J; Cao Y
Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
[TBL] [Abstract][Full Text] [Related]
7. Exosomal lncRNA TUG1 from cancer-associated fibroblasts promotes liver cancer cell migration, invasion, and glycolysis by regulating the miR-524-5p/SIX1 axis.
Lu L; Huang J; Mo J; Da X; Li Q; Fan M; Lu H
Cell Mol Biol Lett; 2022 Feb; 27(1):17. PubMed ID: 35193488
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA.
Chen M; Zhang R; Lu L; Du J; Chen C; Ding K; Wei X; Zhang G; Huang Y; Hou J
Aging (Albany NY); 2020 Nov; 12(21):22291-22312. PubMed ID: 33188158
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p.
Yao Q; Li Y; Pei Y; Xie B
Bioengineered; 2022 Jan; 13(1):1767-1778. PubMed ID: 35012433
[TBL] [Abstract][Full Text] [Related]
10. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
Ma F; Wang SH; Cai Q; Jin LY; Zhou D; Ding J; Quan ZW
Biomed Pharmacother; 2017 Apr; 88():863-869. PubMed ID: 28178615
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
Yang X; Xin N; Qu HJ; Wei L; Han Z
Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
14. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
Tang Y; Yang P; Zhu Y; Su Y
Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation and Invasion in Gastric Cancer via Negatively Modulating miRNA-145-5p.
Ren K; Li Z; Li Y; Zhang W; Han X
Oncol Res; 2017 May; 25(5):789-798. PubMed ID: 27983921
[TBL] [Abstract][Full Text] [Related]
16. BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression.
Liu SC; Cao YH; Chen LB; Kang R; Huang ZX; Lu XS
Cancer Biol Ther; 2022 Dec; 23(1):1-13. PubMed ID: 35998226
[TBL] [Abstract][Full Text] [Related]
17. LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498.
Jin G; Yang Y; Tuo G; Wang W; Zhu Z
Neoplasma; 2020 Jul; 67(4):751-761. PubMed ID: 32305055
[TBL] [Abstract][Full Text] [Related]
18. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA (lncRNA) five prime to Xist (FTX) promotes retinoblastoma progression by regulating the microRNA-320a/with-no-lysine kinases 1 (WNK1) axis.
Wang X; Su Y; Yin C
Bioengineered; 2021 Dec; 12(2):11622-11633. PubMed ID: 34720057
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis.
Zhou L; Jia X; Yang X
Hum Genomics; 2021 Aug; 15(1):50. PubMed ID: 34362467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
